Evogene Schedules Fourth Quarter 2024 Financial Results Release

Rhea-AI Summary

Evogene (Nasdaq: EVGN) (TASE: EVGN), a computational biology company focused on life-science product discovery and development, has announced it will release its fourth quarter 2024 financial results on Thursday, March 6, 2025.

The company will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time) on the same day. Interested parties can register for the Zoom conference call through the provided link. The conference recording will be made available on the company's website following the event.

News Market Reaction

-5.60%

1 alert

-5.60% News Effect

On the day this news was published, EVGN declined 5.60%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Zoom conference call scheduled for March 6, 2025, 9:00 AM ET

REHOVOT, Israel, Feb. 20, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter of 2024, on Thursday, March 6, 2025.

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).

To join the conference, please register in advance:

https://us06web.zoom.us/webinar/register/WN_1cToyoipTfW8X0xtgEqPfw

The entire conference will be available online on the company's website a few days after.

About Evogene:

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.

Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:

1. Biomica Ltd. (www.biomicamed.com) - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
2. Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
3. AgPlenus Ltd. (www.agplenus.com) - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
4. Casterra Ag Ltd. (www.casterra.co) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.

For more information, please visit: www.evogene.com.

Contact

ir@evogene.com
Tel: +972-8-9311901

Logo - https://mma.prnewswire.com/media/1947468/4576969/Evogene_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/evogene-schedules-fourth-quarter-2024-financial-results-release-302381283.html

SOURCE Evogene

FAQ

When will Evogene (EVGN) release its Q4 2024 earnings?

Evogene will release its Q4 2024 financial results on Thursday, March 6, 2025.

What time is Evogene's (EVGN) Q4 2024 earnings call?

Evogene's Q4 2024 earnings conference call is scheduled for 9:00 AM Eastern Time (4:00 PM Israel time) on March 6, 2025.

How can investors join Evogene's (EVGN) Q4 2024 earnings call?

Investors can join by registering in advance through the Zoom webinar link provided by the company.

Will Evogene's (EVGN) Q4 2024 earnings call be available for replay?

Yes, the entire conference will be available for replay on Evogene's website a few days after the live event.